CureGene Pharmaceutical ("CureGene"), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the ...
Baxter International Inc. , a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five ...
2don MSN
Most positive tests for RSV so far this season in Canada have been among the youngest, federal data suggests. And while ...
A scientific statement has been issued by the American Heart Association regarding the management and diagnosis of Kawasaki disease.
Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the ...
Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...
Before vaccines become available, they are tested extensively in labs and in clinical trials ... redness at the site of injection, tiredness, headache, fever and nausea. Infant and Childhood Vaccines ...
The FDA has accepted the New Drug Application for donidalorsen, an investigational RNA-targeted medicine for preventing HAE attacks.
In August last year, the US Food and Drug Administration (FDA) approved Veopoz (pozelimab-bbfg) injection for the treatment ...
What Are GLP-1s? Glucagon-like peptide-1 receptor agonists, also known as GLP-1 drugs, are a class of medications that mimic the action of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback